Exactly what claims AstraZeneca will be able to make on the label for Crestor, and in the advertisements it will use to sell the new drug, will have a huge impact on the company's future.
In January, Pfizer and the FDA added concerns about those side effects to the drug's label, which serves as a guide for doctors and the basis for claims in advertising.